|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
[1-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA |
CTD |
PMID:27837168 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
1-naphthol inhibits the reaction [Metribolone binds to AR protein] |
CTD |
PMID:3695475 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[Pesticides results in increased abundance of 1-naphthol] which results in decreased secretion of BDNF protein |
CTD |
PMID:35292247 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases abundance |
ISO |
CYP1A1 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases abundance affects binding decreases activity |
ISO |
CYP1A2 protein results in increased abundance of 1-naphthol 1-naphthol binds to CYP1A2 protein 1-naphthol results in decreased activity of CYP1A2 protein |
CTD |
PMID:15916432 PMID:16243959 PMID:32278787 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases abundance multiple interactions |
ISO |
CYP1B1 protein results in increased abundance of 1-naphthol [1-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA |
CTD |
PMID:16243959 PMID:27837168 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases abundance multiple interactions |
ISO |
CYP2A13 protein results in increased abundance of 1-naphthol [CYP2A13 protein results in increased oxidation of naphthalene] which results in increased abundance of 1-naphthol |
CTD |
PMID:27137136 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases abundance |
ISO |
CYP2B6 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases abundance multiple interactions |
ISO |
CYP2C19 protein results in increased abundance of 1-naphthol CYP2C19 gene SNP affects the reaction [1-naphthol affects the abundance of Dehydroepiandrosterone Sulfate] |
CTD |
PMID:16243959 PMID:33771511 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
increases abundance |
ISO |
CYP2C8 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases abundance multiple interactions |
ISO |
CYP2D6 protein results in increased abundance of 1-naphthol CYP2D6 gene SNP affects the reaction [1-naphthol affects the abundance of Dehydroepiandrosterone Sulfate] |
CTD |
PMID:16243959 PMID:33771511 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases abundance |
ISO |
CYP2E1 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases abundance |
ISO |
CYP3A4 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases abundance |
ISO |
CYP3A5 protein results in increased abundance of 1-naphthol |
CTD |
PMID:16243959 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
ESR2 protein binds to 1-naphthol 1-naphthol inhibits the reaction [ESR2 protein binds to Estradiol] |
CTD |
PMID:22989670 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression |
ISO |
1-naphthol results in decreased expression of JAG1 mRNA |
CTD |
PMID:22989670 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
EXP |
1-naphthol results in increased activity of NR1I2 protein |
CTD |
PMID:27665777 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
EXP |
1-naphthol results in increased activity of NR1I3 protein |
CTD |
PMID:27665777 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
1-naphthol results in increased expression of NRIP1 mRNA |
CTD |
PMID:22989670 |
|
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases activity |
EXP |
1-naphthol results in increased activity of PPARA protein |
CTD |
PMID:27665777 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases sulfation |
ISO |
SULT1A1 protein results in increased sulfation of 1-naphthol |
CTD |
PMID:15684482 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
1-naphthol binds to and results in decreased activity of THRB protein |
CTD |
PMID:18584933 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
1-naphthol analog results in increased activity of TRPA1 protein |
CTD |
PMID:29658714 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
increases activity |
ISO |
1-naphthol analog results in increased activity of TRPV3 protein |
CTD |
PMID:29658714 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases metabolic processing multiple interactions increases glucuronidation affects metabolic processing |
EXP ISO |
UGT1A6 protein results in increased metabolism of 1-naphthol beta-Naphthoflavone promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Diclofenac inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Indomethacin inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol] Methylcholanthrene promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol]; Paraquat promotes the reaction [UGT1A6 protein results in increased glucuronidation of 1-naphthol] UGT1A6 gene polymorphism affects the metabolism of 1-naphthol; UGT1A6 protein affects the metabolism of 1-naphthol |
CTD |
PMID:7646562 PMID:9429234 PMID:12153725 PMID:12756209 PMID:15336321 PMID:19023562 PMID:22265884 PMID:22846377 More...
|
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of 1-naphthol; UGT1A8 protein results in increased glucuronidation of 1-naphthol |
CTD |
PMID:15502008 PMID:22846377 |
|
NCBI chr 9:88,739,577...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of 1-naphthol |
CTD |
PMID:15044611 PMID:18816295 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2a1 |
UDP glucuronosyltransferase family 2 member A1 |
increases glucuronidation |
ISO |
UGT2A1 protein results in increased glucuronidation of 1-naphthol |
CTD |
PMID:21164388 |
|
NCBI chr14:20,521,018...20,545,934
Ensembl chr14:20,517,951...20,545,531
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases glucuronidation |
EXP |
UGT2B1 protein results in increased glucuronidation of 1-naphthol |
CTD |
PMID:8302279 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of 1-naphthol |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases activity |
ISO EXP |
[Carbaryl co-treated with Dichlorvos] results in decreased activity of ACHE protein; Obidoxime Chloride promotes the reaction [Carbaryl results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [Carbaryl results in decreased activity of ACHE protein] [Carbaryl co-treated with Chlorpyrifos] results in decreased activity of ACHE protein |
CTD |
PMID:4859365 PMID:7713347 PMID:14644616 PMID:16256972 PMID:19934164 PMID:21251949 PMID:23418109 PMID:23962483 PMID:25707986 PMID:33844597 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
decreases activity |
EXP |
Carbaryl results in decreased activity of AGXT protein |
CTD |
PMID:2119399 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO EXP |
AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Carbaryl binds to and results in increased activity of AHR protein; Carbaryl inhibits the reaction [beta-Naphthoflavone binds to and results in increased activity of AHR protein] |
CTD |
PMID:9169082 PMID:9853009 PMID:17553063 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alb |
albumin |
increases hydrolysis multiple interactions |
EXP ISO |
ALB protein results in increased hydrolysis of Carbaryl bis(4-nitrophenyl)phosphate inhibits the reaction [ALB protein results in increased hydrolysis of Carbaryl] |
CTD |
PMID:27665777 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ar |
androgen receptor |
affects binding |
EXP |
Carbaryl binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity multiple interactions |
EXP |
Carbaryl results in decreased activity of BCHE protein [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein |
CTD |
PMID:20708061 PMID:22649187 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
Carbaryl results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
Carbaryl results in increased expression of CASP3 |
CTD |
PMID:27296064 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
Carbaryl results in decreased expression of CEBPA mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
multiple interactions |
EXP |
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein] |
CTD |
PMID:14644616 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
EXP |
Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein] |
CTD |
PMID:14644616 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
EXP |
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:14644616 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
multiple interactions |
EXP |
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein] |
CTD |
PMID:14644616 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity increases expression multiple interactions |
ISO EXP |
Carbaryl results in increased activity of CYP1A1 protein Carbaryl results in increased expression of CYP1A1 mRNA; Carbaryl results in increased expression of CYP1A1 protein AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Methoxsalen inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:9169082 PMID:9858662 PMID:11226373 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression decreases activity |
ISO EXP |
Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] Carbaryl results in increased expression of CYP1A2 protein Carbaryl results in decreased activity of CYP1A2 protein |
CTD |
PMID:9858662 PMID:16790556 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases activity increases expression |
ISO |
Carbaryl results in increased activity of CYP2B6 protein Carbaryl results in increased expression of CYP2B6 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Carbaryl inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] Carbaryl results in decreased activity of CYP2E1 protein |
CTD |
PMID:22634058 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Carbaryl results in increased expression of CYP3A4 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Carbaryl results in increased expression of DDIT3 mRNA |
CTD |
PMID:11226373 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Carbaryl results in increased expression of DNAJB4 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
ISO |
Carbaryl results in increased expression of DNAJB9 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
ISO |
Carbaryl results in increased expression of DNAJC3 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Carbaryl results in decreased expression of E2F5 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
decreases expression |
ISO |
Carbaryl results in decreased expression of ENC1 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Carbaryl binds to and results in decreased activity of ESR1 protein; Carbaryl inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:9126867 PMID:16626760 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions decreases expression |
ISO |
Carbaryl binds to and results in decreased activity of ESR2 protein Carbaryl results in decreased expression of ESR2 mRNA |
CTD |
PMID:16626760 PMID:27829164 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression decreases expression |
ISO |
Carbaryl results in increased expression of FOS mRNA Carbaryl results in decreased expression of FOS mRNA |
CTD |
PMID:11226373 PMID:27829164 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression |
ISO |
Carbaryl results in decreased expression of FOXO1 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA]; Carbaryl inhibits the reaction [FSHB protein results in increased secretion of Progesterone] |
CTD |
PMID:16413094 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity multiple interactions |
EXP |
Carbaryl results in increased activity of G6PD protein [Malathion co-treated with Carbaryl] results in increased activity of G6PD protein; Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein] |
CTD |
PMID:27214522 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
decreases expression |
ISO |
Carbaryl results in decreased expression of GADD45B mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Carbaryl results in increased expression of GCLM mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx5 |
glutathione peroxidase 5 |
increases expression |
ISO |
Carbaryl results in increased expression of GPX5 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr17:43,436,126...43,443,074
Ensembl chr17:43,416,340...43,443,074
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
increases expression |
EXP |
Carbaryl results in increased expression of GRIN2B protein |
CTD |
PMID:28975519 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
ISO |
Carbaryl results in increased expression of HERPUD1 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Carbaryl results in increased expression of HMOX1 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Carbaryl results in increased expression of HSPA5 mRNA |
CTD |
PMID:11226373 PMID:27829164 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
decreases expression |
ISO |
Carbaryl results in decreased expression of HSPA6 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein] |
CTD |
PMID:15907790 PMID:18177342 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Il2 |
interleukin 2 |
decreases response to substance |
ISO |
Carbaryl analog results in decreased susceptibility to IL2 protein; Carbaryl results in decreased susceptibility to IL2 protein |
CTD |
PMID:8349949 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
decreases activity |
EXP |
Carbaryl results in decreased activity of KYAT1 protein |
CTD |
PMID:2119399 |
|
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
|
|
G |
Map2 |
microtubule-associated protein 2 |
multiple interactions |
ISO |
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] |
CTD |
PMID:32949729 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mitf |
melanocyte inducing transcription factor |
decreases expression |
ISO |
Carbaryl results in decreased expression of MITF mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Mtnr1a |
melatonin receptor 1A |
affects binding multiple interactions |
ISO |
Carbaryl binds to MTNR1A protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1A protein] |
CTD |
PMID:28027439 |
|
NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919
|
|
G |
Mtnr1b |
melatonin receptor 1B |
affects binding multiple interactions |
ISO |
Carbaryl binds to MTNR1B protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]; Guanosine Triphosphate inhibits the reaction [Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]] |
CTD |
PMID:28027439 |
|
NCBI chr 8:12,638,219...12,652,737
Ensembl chr 8:12,638,219...12,652,737
|
|
G |
Nefh |
neurofilament heavy chain |
increases phosphorylation |
ISO |
Carbaryl results in increased phosphorylation of NEFH protein |
CTD |
PMID:16256972 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] |
CTD |
PMID:15907790 PMID:17015962 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] |
CTD |
PMID:15907790 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression increases activity |
ISO EXP |
Carbaryl results in increased expression of NR1I2 mRNA Carbaryl results in increased activity of NR1I2 protein |
CTD |
PMID:22310298 PMID:27665777 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
EXP |
Carbaryl results in increased activity of NR1I3 protein |
CTD |
PMID:27665777 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Otx2 |
orthodenticle homeobox 2 |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA] |
CTD |
PMID:32949729 |
|
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
|
|
G |
Pax6 |
paired box 6 |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of PAX6 mRNA] |
CTD |
PMID:32949729 |
|
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pdxk |
pyridoxal kinase |
decreases activity |
ISO |
Carbaryl results in decreased activity of PDXK protein |
CTD |
PMID:2547861 |
|
NCBI chr20:10,210,276...10,232,314
Ensembl chr20:10,210,289...10,232,110
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [Progesterone results in increased activity of PGR protein] |
CTD |
PMID:9126867 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
decreases activity |
EXP |
Carbaryl results in decreased activity of PNPLA6 protein |
CTD |
PMID:7713347 |
|
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA] |
CTD |
PMID:32949729 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases activity |
EXP |
Carbaryl results in increased activity of PPARA protein |
CTD |
PMID:27665777 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:15907790 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
ISO |
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA] Carbaryl results in decreased expression of STAR mRNA |
CTD |
PMID:16413094 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases activity |
ISO EXP |
Carbaryl results in decreased activity of TDO2 protein |
CTD |
PMID:2119399 PMID:2547861 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
ISO |
Carbaryl results in increased expression of TGFB2 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions affects binding |
ISO |
Carbaryl binds to and results in decreased activity of THRB protein Carbaryl binds to THRB protein |
CTD |
PMID:18584933 PMID:28973306 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tpo |
thyroid peroxidase |
increases activity |
ISO |
Carbaryl results in increased activity of TPO protein |
CTD |
PMID:21809831 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Wnt6 |
Wnt family member 6 |
decreases expression |
ISO |
Carbaryl results in decreased expression of WNT6 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases expression |
ISO |
Carbaryl results in increased expression of XBP1 mRNA |
CTD |
PMID:27829164 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Aanat |
aralkylamine N-acetyltransferase |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Parathion results in increased expression of AANAT protein] |
CTD |
PMID:10685507 |
|
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression multiple interactions |
ISO |
Propranolol results in increased expression of ABCB1 mRNA Propranolol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
CTD |
PMID:15276086 PMID:16671962 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ada |
adenosine deaminase |
multiple interactions |
EXP |
Propranolol promotes the reaction [ADA protein results in decreased susceptibility to Norepinephrine] |
CTD |
PMID:7949234 |
|
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Adm |
adrenomedullin |
decreases response to substance |
EXP |
Propranolol results in decreased susceptibility to ADM protein |
CTD |
PMID:9845272 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
multiple interactions affects response to substance affects binding increases activity increases expression |
EXP ISO |
Propranolol binds to and results in decreased activity of ADRB1 protein; Propranolol inhibits the reaction [CGP 12177 binds to ADRB1 protein]; Propranolol inhibits the reaction [Dihydroalprenolol binds to ADRB1 protein] ADRB1 protein polymorphism affects the susceptibility to Propranolol Propranolol binds to ADRB1 protein [Propranolol binds to and results in decreased activity of ADRB1 protein] which results in decreased abundance of Cyclic AMP; [Propranolol co-treated with ADRB1] results in increased abundance of Cyclic AMP; Propranolol binds to and results in decreased activity of ADRB1 protein; Propranolol inhibits the reaction [[CGP 12177 binds to ADRB1 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [CGP 12177 results in increased activity of ADRB1 protein]; Propranolol inhibits the reaction [cyanopindolol binds to ADRB1 protein]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of ADRB1 protein]; Propranolol inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRB1 protein] Propranolol results in increased activity of ADRB1 protein Propranolol results in increased expression of ADRB1 mRNA |
CTD |
PMID:2462161 PMID:6141285 PMID:9593075 PMID:10372227 PMID:10952688 PMID:11425575 PMID:11483288 PMID:12761341 PMID:14502278 PMID:14730417 PMID:15060759 PMID:15627480 PMID:17200720 PMID:18787115 PMID:20668454 More...
|
|
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
decreases expression multiple interactions affects binding increases expression |
ISO EXP |
Propranolol results in decreased expression of ADRB2 mRNA Propranolol binds to and results in decreased activity of ADRB2 protein; Propranolol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; Propranolol inhibits the reaction [Dihydroalprenolol binds to ADRB2 protein] Propranolol binds to ADRB2 protein Propranolol results in increased expression of ADRB2 mRNA [Propranolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP; [Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; [Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein; [Propranolol co-treated with ADRB2 protein] results in increased expression of GRK2 protein; Propranolol binds to and results in decreased activity of ADRB2 protein; Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; Propranolol inhibits the reaction [Albuterol binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB2 protein binds to ARRB2 protein]]; Propranolol inhibits the reaction [carvedilol results in increased phosphorylation of ADRB2 protein]; Propranolol inhibits the reaction [cyanopindolol binds to ADRB2 protein]; Propranolol inhibits the reaction [Epinephrine binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; Propranolol inhibits the reaction [Norepinephrine binds to ADRB2 protein]; Propranolol inhibits the reaction [Terbutaline binds to and results in increased activity of ADRB2 protein] |
CTD |
PMID:2169833 PMID:2462161 PMID:2897299 PMID:6141285 PMID:9593075 PMID:10372227 PMID:10455254 PMID:10952688 PMID:11425575 PMID:11483288 PMID:12920204 PMID:14730417 PMID:15603589 PMID:17925438 PMID:20668454 PMID:24929186 More...
|
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
multiple interactions affects response to substance |
ISO |
Propranolol inhibits the reaction [cyanopindolol binds to ADRB3 protein] ADRB3 affects the susceptibility to Propranolol |
CTD |
PMID:11159692 PMID:14730417 |
|
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
|
|
G |
Agt |
angiotensinogen |
multiple interactions decreases expression |
ISO |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of AGT protein]; Propranolol inhibits the reaction [REN protein results in increased cleavage of AGT protein] Propranolol inhibits the reaction [AGT protein modified form results in increased abundance of Superoxides]; Propranolol inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]] Propranolol results in decreased expression of AGT protein |
CTD |
PMID:14627 PMID:1653766 PMID:7104148 PMID:7843740 PMID:12606818 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
Propranolol results in decreased phosphorylation of AKT1 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:30130526 PMID:31838054 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
ISO |
1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] |
CTD |
PMID:18218859 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Amy2a3 |
amylase 2a3 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased secretion of and results in increased activity of AMY1A protein] |
CTD |
PMID:21173550 |
|
NCBI chr 2:201,317,916...201,326,487
Ensembl chr 2:201,317,920...201,326,532
|
|
G |
Angpt2 |
angiopoietin 2 |
decreases expression multiple interactions |
ISO |
Propranolol results in decreased expression of ANGPT2 mRNA; Propranolol results in decreased expression of ANGPT2 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of BCL2 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in decreased phosphorylation of AKT1 protein]; ANGPT2 protein inhibits the reaction [Propranolol results in increased expression of BAX protein] |
CTD |
PMID:31838054 |
|
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Arf6 |
ARF GTPase 6 |
affects localization |
ISO |
Propranolol affects the localization of ARF6 protein |
CTD |
PMID:16280360 |
|
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
|
|
G |
Arrb2 |
arrestin, beta 2 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB2 protein binds to ARRB2 protein]] |
CTD |
PMID:17925438 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Terbutaline results in increased expression of ATP1A1 mRNA] |
CTD |
PMID:9700104 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions increases expression |
EXP ISO |
Propranolol results in decreased expression of BAX mRNA Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein] Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased expression of BAX protein] ANGPT2 protein inhibits the reaction [Propranolol results in increased expression of BAX protein] |
CTD |
PMID:11218852 PMID:31838054 PMID:35738838 PMID:36707890 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions decreases expression |
EXP ISO |
Propranolol results in increased expression of BCL2 mRNA Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] Propranolol results in decreased expression of BCL2 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of BCL2 protein] |
CTD |
PMID:11218852 PMID:31838054 PMID:36707890 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
multiple interactions |
ISO |
BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine] |
CTD |
PMID:10614985 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions affects activity |
EXP |
Propranolol promotes the reaction [CALCA protein affects the susceptibility to Norepinephrine] Propranolol affects the activity of CALCA protein |
CTD |
PMID:7906887 PMID:8058111 PMID:10075105 PMID:18055875 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions increases activity decreases expression |
ISO EXP |
Propranolol results in increased cleavage of CASP3 protein Acetylcysteine inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein]; Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased cleavage of CASP3 protein] Propranolol results in increased activity of CASP3 protein Palmitic Acid promotes the reaction [Propranolol results in increased activity of CASP3 protein] Propranolol results in decreased expression of CASP3 mRNA |
CTD |
PMID:11218852 PMID:19106745 PMID:22700542 PMID:35738838 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity |
ISO |
Propranolol results in increased activity of CASP7 protein |
CTD |
PMID:22700542 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
ISO EXP |
Propranolol results in increased cleavage of CASP9 protein Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased cleavage of CASP9 protein] |
CTD |
PMID:19106745 PMID:35738838 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Epinephrine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL3 protein]] Propranolol inhibits the reaction [Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Propranolol promotes the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein] |
CTD |
PMID:9863660 PMID:12538206 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 mRNA]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of COL2A1 protein] |
CTD |
PMID:21177286 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of CREB1 protein] |
CTD |
PMID:15522277 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
EXP |
Propranolol affects the reaction [Norepinephrine affects the expression of and affects the secretion of CRH protein]; Propranolol inhibits the reaction [acephate results in increased expression of CRH mRNA]; Propranolol inhibits the reaction [acephate results in increased secretion of CRH protein]; Propranolol inhibits the reaction [methamidophos results in increased expression of CRH mRNA]; Propranolol inhibits the reaction [methamidophos results in increased secretion of CRH protein] |
CTD |
PMID:3497798 PMID:12039681 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO EXP |
Propranolol results in increased expression of CYP1A1 protein Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A1 protein]] Propranolol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:15618653 PMID:15627480 PMID:15710352 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects metabolic processing increases expression multiple interactions |
ISO EXP |
CYP1A2 protein affects the metabolism of Propranolol Propranolol results in increased expression of CYP1A2 protein Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]]; Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] |
CTD |
PMID:15286053 PMID:15618653 PMID:15710352 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:22167199 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases oxidation affects metabolic processing |
ISO |
CYP2C19 protein results in increased oxidation of Propranolol CYP2C19 protein affects the metabolism of Propranolol |
CTD |
PMID:15286053 PMID:19853591 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [CYP2D2 protein results in increased metabolism of 3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin] |
CTD |
PMID:19858067 |
|
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases metabolic processing increases oxidation affects metabolic processing |
ISO |
CYP2D6 protein results in increased metabolism of Propranolol CYP2D6 protein results in increased oxidation of Propranolol CYP2D6 protein affects the metabolism of Propranolol |
CTD |
PMID:12464242 PMID:15286053 PMID:19853591 PMID:21184751 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases oxidation |
ISO |
CYP3A4 protein results in increased oxidation of Propranolol |
CTD |
PMID:19853591 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
decreases expression multiple interactions |
ISO |
Propranolol results in decreased expression of DLL4 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP2 protein]; DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein] |
CTD |
PMID:30130526 |
|
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Alprenolol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]; Propranolol inhibits the reaction [Dobutamine promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]] |
CTD |
PMID:18787115 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] |
CTD |
PMID:15621046 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
EXP |
[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:11880281 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression |
EXP |
Propranolol results in decreased expression of FAS mRNA |
CTD |
PMID:11218852 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
EXP |
Propranolol results in increased expression of FGF1 mRNA |
CTD |
PMID:15264218 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases oxidation |
ISO |
FMO2 protein results in increased oxidation of Propranolol |
CTD |
PMID:26062974 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
[Norepinephrine co-treated with Propranolol] results in increased expression of FN1 protein |
CTD |
PMID:11821714 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
Propranolol inhibits the reaction [3-(N-phenylamino)-1,2-propanediol 1,2-dioleoyl ester analog results in increased expression of FOS mRNA]; Propranolol inhibits the reaction [Ethanol results in increased expression of FOS protein]; Propranolol inhibits the reaction [Haloperidol results in increased expression of FOS protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of FOS] Propranolol results in increased expression of FOS protein |
CTD |
PMID:7905536 PMID:9748542 PMID:15501433 PMID:22236039 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Amphetamine inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]]; Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [3-acetylpyridine results in increased expression of GAD1 mRNA]] |
CTD |
PMID:8774452 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
affects localization |
EXP |
Propranolol affects the localization of GJA1 protein |
CTD |
PMID:17445419 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gk |
glycerol kinase |
decreases activity |
EXP |
Propranolol results in decreased activity of GK protein |
CTD |
PMID:12736183 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gnas |
GNAS complex locus |
increases expression multiple interactions |
EXP ISO |
Propranolol results in increased expression of GNAS mRNA Propranolol inhibits the reaction [Isoproterenol results in increased palmitoylation of GNAS protein] [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein |
CTD |
PMID:9732414 PMID:10455254 PMID:20668454 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
multiple interactions increases expression decreases expression |
ISO |
[Propranolol co-treated with ADRB2 protein] results in increased expression of GRK2 protein Propranolol results in increased expression of GRK2 protein Propranolol results in decreased expression of GRK2 protein |
CTD |
PMID:9788834 PMID:10455254 |
|
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
EXP |
Propranolol results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:22982863 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of HMOX1 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of HMOX1 mRNA] |
CTD |
PMID:19483313 PMID:24929186 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpca |
hippocalcin |
affects localization |
EXP |
Propranolol affects the localization of HPCA protein |
CTD |
PMID:21078978 |
|
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
affects binding |
EXP |
Propranolol binds to HTR1B protein |
CTD |
PMID:11888550 |
|
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
|
|
G |
Il10 |
interleukin 10 |
increases expression |
EXP |
Propranolol results in increased expression of IL10 mRNA |
CTD |
PMID:16908771 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases secretion |
ISO EXP |
Propranolol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] Propranolol results in decreased secretion of IL1B protein |
CTD |
PMID:11854442 PMID:16386803 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Norepinephrine results in increased expression of IL6 mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of IL6 mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of IL6 protein] |
CTD |
PMID:12619890 PMID:29247675 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions decreases expression |
ISO |
Propranolol inhibits the reaction [Epinephrine results in decreased expression of INS protein] Propranolol results in decreased expression of INS protein |
CTD |
PMID:3019152 PMID:6018752 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Kcne2 |
potassium voltage-gated channel subfamily E regulatory subunit 2 |
multiple interactions |
ISO |
Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein] |
CTD |
PMID:15679475 |
|
NCBI chr11:31,517,176...31,530,026
Ensembl chr11:31,295,614...31,530,043
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
ISO |
Propranolol results in decreased activity of [KCNH2 protein binds to KCNE2 protein]; Propranolol results in decreased activity of [KCNH2 protein binds to KCNH2 protein] Propranolol results in decreased activity of KCNH2 protein |
CTD |
PMID:15679475 PMID:16314852 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
affects response to substance |
ISO |
KCNJ2 gene affects the susceptibility to Propranolol |
CTD |
PMID:15028050 |
|
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
increases expression |
ISO |
Propranolol results in increased expression of KCNJ3 mRNA |
CTD |
PMID:15603589 |
|
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
affects response to substance |
ISO |
KCNQ1 gene affects the susceptibility to Propranolol |
CTD |
PMID:15028050 |
|
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Lep |
leptin |
multiple interactions increases expression |
ISO EXP |
Propranolol inhibits the reaction [Isoproterenol results in decreased secretion of LEP protein] Propranolol results in increased expression of LEP protein |
CTD |
PMID:11022189 PMID:24250662 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
increases expression |
EXP |
Propranolol results in increased expression of LEPR mRNA |
CTD |
PMID:24250662 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] |
CTD |
PMID:9032464 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
[Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK1 protein; Propranolol inhibits the reaction [Nicotine results in decreased phosphorylation of MAPK1 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein] 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein; Cadmium Chloride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; cadmium sulfate inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; N,N'-bis(salicylideneamino)ethane-manganese(II) inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; oxophenylarsine inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK1 protein]; Propranolol inhibits the reaction [Colforsin results in increased activity of MAPK1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK1 protein] |
CTD |
PMID:11093795 PMID:11880281 PMID:17925438 PMID:18448488 PMID:19903766 PMID:20106947 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
[Propranolol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; Propranolol inhibits the reaction [Nicotine results in decreased phosphorylation of MAPK3 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein] 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; [Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein; Cadmium Chloride inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; cadmium sulfate inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; diphenyleneiodonium inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; N,N'-bis(salicylideneamino)ethane-manganese(II) inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; oxophenylarsine inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Prazosin inhibits the reaction [[Norepinephrine co-treated with Propranolol] results in increased phosphorylation of MAPK3 protein]; Propranolol inhibits the reaction [Colforsin results in increased activity of MAPK3 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of MAPK3 protein] |
CTD |
PMID:11093795 PMID:11880281 PMID:17925438 PMID:18448488 PMID:19903766 PMID:20106947 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of MCL1 protein] |
CTD |
PMID:19903766 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mir34a |
microRNA 34a |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of MIR34A mRNA] |
CTD |
PMID:36707890 |
|
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression multiple interactions |
ISO |
Propranolol results in decreased expression of MKI67 protein ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein] |
CTD |
PMID:31838054 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions decreases secretion |
ISO |
Propranolol results in decreased expression of MMP2; Propranolol results in decreased expression of MMP2 mRNA; Propranolol results in decreased expression of MMP2 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP2 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA] Propranolol results in decreased secretion of MMP2 protein |
CTD |
PMID:20424515 PMID:21042766 PMID:24929186 PMID:30130526 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions decreases secretion |
ISO |
Propranolol results in decreased expression of MMP9; Propranolol results in decreased expression of MMP9 mRNA; Propranolol results in decreased expression of MMP9 protein DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]; Propranolol inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA] Propranolol results in decreased secretion of MMP9 protein |
CTD |
PMID:16574429 PMID:20424515 PMID:21042766 PMID:24929186 PMID:30130526 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions increases expression |
EXP |
Propranolol promotes the reaction [Norepinephrine results in increased expression of MYH7 mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA] Propranolol results in increased expression of MYH7 mRNA |
CTD |
PMID:17592507 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression |
EXP |
Propranolol affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of NGF mRNA] |
CTD |
PMID:2174743 PMID:2853697 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos3 |
nitric oxide synthase 3 |
affects expression |
EXP |
Propranolol affects the expression of NOS3 |
CTD |
PMID:10889169 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
Propranolol results in decreased expression of NOTCH1 protein |
CTD |
PMID:30130526 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions affects activity increases expression |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA]; Propranolol promotes the reaction [Norepinephrine results in increased expression of NPPA mRNA]; Propranolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] Propranolol affects the activity of NPPA protein modified form Propranolol results in increased expression of NPPA mRNA |
CTD |
PMID:1363893 PMID:10997724 PMID:17592507 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
affects activity |
EXP |
Propranolol affects the activity of NPPB protein modified form |
CTD |
PMID:1363893 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Propranolol results in increased activity of NR1I2 protein |
CTD |
PMID:28259787 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases activity multiple interactions |
ISO |
Propranolol results in increased activity of ODC1 protein Propranolol inhibits the reaction [Clenbuterol results in increased activity of ODC1 protein]; Propranolol inhibits the reaction [Isoproterenol results in increased activity of ODC1 protein] |
CTD |
PMID:2286747 PMID:6284819 PMID:10353628 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Orm1 |
orosomucoid 1 |
affects binding |
EXP |
propranolol affects binding to Orm1 protein in rat serum |
RGD |
PMID:3252025 |
RGD:2316648 |
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Penk |
proenkephalin |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of PENK mRNA] |
CTD |
PMID:1363325 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Pln |
phospholamban |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in decreased expression of and results in decreased phosphorylation of PLN protein] |
CTD |
PMID:10997724 |
|
NCBI chr20:32,629,537...32,639,559
|
|
G |
Pomc |
proopiomelanocortin |
increases secretion |
EXP |
Propranolol results in increased secretion of POMC protein |
CTD |
PMID:22236039 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions decreases expression |
ISO |
[Propranolol co-treated with Prazosin] inhibits the reaction [Norepinephrine results in increased expression of PPARGC1A mRNA]; Propranolol inhibits the reaction [Clenbuterol results in increased expression of PPARGC1A mRNA] Propranolol results in decreased expression of PPARGC1A mRNA |
CTD |
PMID:16513826 PMID:17446185 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prkca |
protein kinase C, alpha |
decreases expression |
EXP |
Propranolol results in decreased expression of PRKCA protein |
CTD |
PMID:20668454 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcd |
protein kinase C, delta |
decreases expression |
EXP |
Propranolol results in decreased expression of PRKCD protein |
CTD |
PMID:20668454 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO |
Propranolol inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein]; Propranolol inhibits the reaction [Nicotine results in increased activity of PTGS2 protein]; Propranolol promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]; Propranolol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Propranolol results in decreased expression of PTGS2; Propranolol results in decreased expression of PTGS2 mRNA; Propranolol results in decreased expression of PTGS2 protein |
CTD |
PMID:11854442 PMID:12872987 PMID:15210717 PMID:18805435 PMID:20424515 PMID:21042766 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Isoproterenol results in increased expression of PTPN5 protein] |
CTD |
PMID:17623046 |
|
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
|
|
G |
Ren |
renin |
multiple interactions decreases activity decreases expression |
ISO EXP |
Propranolol affects the reaction [Anesthetics, Combined results in increased activity of REN protein]; Propranolol affects the reaction [Nitroprusside promotes the reaction [Anesthetics, Combined results in increased activity of REN protein]]; Propranolol inhibits the reaction [Isoproterenol results in increased expression of REN protein]; Propranolol inhibits the reaction [Nitroprusside results in increased activity of REN protein]; Propranolol inhibits the reaction [REN protein results in increased cleavage of AGT protein] Propranolol results in decreased activity of REN protein Propranolol inhibits the reaction [ioxitalamic acid results in increased expression of REN protein]; Propranolol inhibits the reaction [Prazosin results in increased transport of REN protein]; Propranolol inhibits the reaction [Yohimbine results in increased expression of REN protein] Propranolol results in decreased expression of REN protein |
CTD |
PMID:145319 PMID:200433 PMID:637424 PMID:653302 PMID:791319 PMID:1103606 PMID:1653766 PMID:3539430 PMID:6110712 PMID:6323192 PMID:6346849 PMID:6434220 PMID:7020487 PMID:7104148 PMID:7988622 PMID:19945959 More...
|
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation multiple interactions |
ISO |
Propranolol results in increased phosphorylation of RPS6KB1 protein Sirolimus inhibits the reaction [Propranolol results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:16537399 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
multiple interactions |
EXP |
Propranolol inhibits the reaction [Terbutaline results in increased expression of SCNN1A mRNA] |
CTD |
PMID:9700104 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Serpinf1 |
serpin family F member 1 |
increases expression |
ISO |
propranolol increases expression of Serpinf1 protein in mononuclear phagocytes |
RGD |
PMID:31682714 |
RGD:27226692 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of SIRT1 mRNA]; Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of SIRT1 protein] |
CTD |
PMID:36707890 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:21641380 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Propranolol inhibits the reaction [SLC22A2 protein results in increased uptake of Metformin] |
CTD |
PMID:19740083 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:21641380 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC22A4 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:21641380 |
|
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine] |
CTD |
PMID:21641380 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein] |
CTD |
PMID:15621046 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:18448488 PMID:20106947 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Sts |
steroid sulfatase |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Tretinoin results in increased activity of STS protein] |
CTD |
PMID:16178010 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Tek |
TEK receptor tyrosine kinase |
decreases expression |
ISO |
Propranolol results in decreased expression of TEK mRNA; Propranolol results in decreased expression of TEK protein |
CTD |
PMID:31838054 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
multiple interactions |
ISO |
Propranolol inhibits the reaction [Epinephrine results in decreased expression of THY1]; Propranolol inhibits the reaction [Isoproterenol results in decreased expression of THY1]; Propranolol inhibits the reaction [Norepinephrine results in decreased expression of THY1] |
CTD |
PMID:7558147 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
Propranolol inhibits the reaction [Dopamine inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of TNF protein]]; Propranolol inhibits the reaction [Ozone results in increased expression of TNF mRNA]; Propranolol inhibits the reaction [Ozone results in increased expression of TNF protein]; Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein] Propranolol results in increased expression of TNF protein |
CTD |
PMID:11752888 PMID:15081246 PMID:29247675 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
increases glucuronidation |
EXP |
UGT2B protein results in increased glucuronidation of Propranolol |
CTD |
PMID:15801678 |
|
NCBI chr14:20,630,572...20,665,062
Ensembl chr14:20,630,250...20,651,776
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions |
ISO |
Propranolol results in decreased expression of VEGFA mRNA; Propranolol results in decreased expression of VEGFA protein Propranolol inhibits the reaction [Norepinephrine results in increased expression of VEGFA mRNA] |
CTD |
PMID:10788502 PMID:20424515 PMID:30130526 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
decreases binding |
EXP |
propranolol hydrochloride decreases binding to the beta2-adrenergic receptor |
RGD |
PMID:12875885 |
RGD:1598755 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|